CAMKK2 and familial dilated cardiomyopathy: The present study elucidated the therapeutic potential and mechanism of BH4 during late-stage DCM and its ability to improve mitochondrial energy metabolism via CaMKK2 and downstream CREB/PGC-1α signaling (Fig 7F).